Keyphrases
Phase II Trial
100%
Electrophysiology
100%
Ventricular Tachycardia
100%
Cardiac Ablation
100%
Premature Ventricular Contraction
62%
Cardiomyopathy
25%
Serious Adverse Events
25%
Stereotactic Body Radiation Therapy
25%
Antiarrhythmic Drugs
25%
Treatment-related
25%
First 90
25%
Overall Survival
12%
Risk Reduction
12%
Quality of Life
12%
Short Form 36 (SF-36)
12%
Nineteen
12%
Drug Use
12%
Anatomic
12%
Catheter
12%
Interventional Electrophysiology
12%
Health-related Quality of Life
12%
Short Form 36 Questionnaire
12%
Primary Safety
12%
Scar
12%
Cardiac Imaging
12%
Ventricular Arrhythmia
12%
Implantable Defibrillator
12%
Holter Monitor
12%
Quality of Life Improvement
12%
Implantable Cardioverter-defibrillator Shock
12%
Antitachycardia Pacing
12%
Treatment Refractory
12%
Ablation Time
12%
Single Fraction
12%
Electric
12%
Short-term Risk
12%
Arrhythmic Burden
12%
Non-thermal Ablation
12%
Medicine and Dentistry
Electrophysiology
100%
Ventricular Tachycardia
100%
Premature Ventricular Contraction
62%
Quality of Life
37%
Adverse Event
25%
Implantable Automatic Defibrillator
25%
Stereotactic Body Radiation Therapy
25%
Short Form 36
25%
Myocardial Disease
25%
Overall Survival
12%
Antiarrhythmic Agent
12%
Shock (Circulatory)
12%
Drug Use
12%
Cardiac Imaging
12%
Heart Ventricle Arrhythmia
12%
Risk Reduction
12%
Antitachycardia Pacing
12%
Antiarrhythmic Drug
12%